Latest GSK News & Updates

See the latest news and media coverage for GSK. We track all announcements, press releases, and industry mentions in real time, all in one place.

GSK

Global biopharmaceutical company

gsk.com

Headquarters: London, United Kingdom
Company type: Public company
Number of employees: 90,000+

Last updated Today

Latest news about GSK

In short: GSK expanded its oncology and respiratory portfolios through the $10.6 billion acquisition of Nuvalent and multiple FDA regulatory approvals.

Company announcements

June 17 GSK

GSK's Utebzi approved in US for complicated UTIs

It is the first oral carbapenem antibiotic, offering alternative to IV therapy for patients with limited oral options.

June 12 GSK

GSK's momelotinib received Orphan Drug Designations for VEXAS syndrome

The FDA and EMA granted the designations, supporting development for a rare life-threatening condition with no approved treatments.

June 9 GSK

GSK acquires Nuvalent for $10.6 billion

The deal includes two late-stage lung cancer drugs and is expected to be accretive from 2027.

May 28 GSK

GSK announces bepirovirsen achieves functional cure in hepatitis B trials

Pivotal B-Well data show 19% functional cure rate, 26% in lower viral activity, vs 0% for standard of care.

Media coverage

June 22 Bez Kabli

GSK Stock Slips as Tivicay Priority Review Sets Up Busy FDA Calendar (LSE:GSK)

GSK Stock Slips as Tivicay Priority Review Sets Up Busy FDA Calendar (LSE:GSK) - Bez Kabli...

June 22 Medscape

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

Adding the PD-1 inhibitor dostarlimab to standard chemotherapy provides sustained survival benefits...

June 17 Fierce Pharma

4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line

GSK and Spero Therapeutics have scored an FDA approval for Utebzi as the first oral carbapenem antibiotic for complicated urinary tract infections (cUTI). With the...

June 17 Reuters

US FDA approves GSK s oral antibiotic for drug-resistant UTIs

, opens new tab oral antibiotic to treat complicated urinary tract infections, the regulator said on...

Never miss news about GSK

Track GSK and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

GSK competitors & trending companies

Browse news for competitors to GSK and other trending companies.